Various studies have shown that low baseline CD4 count and advance disease stage were significant predictors of treatment failure explained by the frequent occurrence of opportunistic infections that leads to disease progression subsequently increased risk of failure [25, 27, 32, 39]. This evidence concerns the gene CD4 and Opportunistic infection.